Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
45.3% achieved 30% weight loss
Patients with type-two diabetes are eligible for Mounjaro, and the FDA has approved Zepbound for adults with a minimum BMI of 30, or 27 if a patient also has a weight-related condition, such as high blood pressure, heart disease, sleep apnea, or prediabetes
10.3390/medsci10020024 18 ChandraU.YadavA.KumarD.SahaS
Younger adults, meanwhile, are more likely to use GLP-1 drugs solely for weight loss, according to the KFF study
The approval is based on a study showing that 2.4 mg of semaglutide the generic name for Wegovy reduced the incidence of non-fatal heart attacks, non-fatal strokes, and mortality from heart disease
US$ 21.22
US$ 28.72
US$ 28.74
US$ 23.35
